Bonus-Zertifikate finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
112 Ergebnisse
| PJ1QE0 |  | BioNTech SE (ADRs)/CapBonus/95/Call/BNP | - | - | BioNTech SE (ADRs) | 95,000 | 16,847 % | -2,892 % | 29,600 % | 65,000 | 24.12.2026 | BNP Paribas | |
| PJ1QE1 | | BioNTech SE (ADRs)/CapBonus/100/Call/BNP | - | - | BioNTech SE (ADRs) | 100,000 | 23,814 % | -8,307 % | 24,185 % | 70,000 | 24.12.2026 | BNP Paribas | |
| PJ1QE2 | | BioNTech SE (ADRs)/CapBonus/120/Call/BNP | - | - | BioNTech SE (ADRs) | 120,000 | 32,208 % | -29,969 % | 24,185 % | 70,000 | 24.12.2026 | BNP Paribas | |
| PJ1QE3 | | BioNTech SE (ADRs)/CapBonus/95/Call/BNP | - | - | BioNTech SE (ADRs) | 95,000 | 25,534 % | -2,892 % | 18,770 % | 75,000 | 24.12.2026 | BNP Paribas | |
| PJ1QE4 | | BioNTech SE (ADRs)/CapBonus/110/Call/BNP | - | - | BioNTech SE (ADRs) | 110,000 | 38,660 % | -19,138 % | 18,770 % | 75,000 | 24.12.2026 | BNP Paribas | |
| PJ1QEP | | BioNTech SE (ADRs)/CapBonus/84/Call/BNP | - | - | BioNTech SE (ADRs) | 84,000 | - | 9,022 % | 35,016 % | 60,000 | 24.09.2026 | BNP Paribas | |
| PJ1QEQ | | BioNTech SE (ADRs)/CapBonus/100/Call/BNP | - | - | BioNTech SE (ADRs) | 100,000 | - | -8,307 % | 35,016 % | 60,000 | 24.09.2026 | BNP Paribas | |
| PJ1QER | | BioNTech SE (ADRs)/CapBonus/76/Call/BNP | - | - | BioNTech SE (ADRs) | 76,000 | - | 17,687 % | 29,600 % | 65,000 | 24.09.2026 | BNP Paribas | |
| PJ1QES | | BioNTech SE (ADRs)/CapBonus/92/Call/BNP | - | - | BioNTech SE (ADRs) | 92,000 | - | 0,357 % | 29,600 % | 65,000 | 24.09.2026 | BNP Paribas | |
| PJ1QET | | BioNTech SE (ADRs)/CapBonus/92/Call/BNP | - | - | BioNTech SE (ADRs) | 92,000 | - | 0,357 % | 24,185 % | 70,000 | 24.09.2026 | BNP Paribas | |
| PJ1QEU | | BioNTech SE (ADRs)/CapBonus/120/Call/BNP | - | - | BioNTech SE (ADRs) | 120,000 | - | -29,969 % | 24,185 % | 70,000 | 24.09.2026 | BNP Paribas | |
| PJ1QEV | | BioNTech SE (ADRs)/CapBonus/90/Call/BNP | - | - | BioNTech SE (ADRs) | 90,000 | - | 2,524 % | 18,770 % | 75,000 | 24.09.2026 | BNP Paribas | |
| PJ1QEW | | BioNTech SE (ADRs)/CapBonus/110/Call/BNP | - | - | BioNTech SE (ADRs) | 110,000 | - | -19,138 % | 18,770 % | 75,000 | 24.09.2026 | BNP Paribas | |
| PJ1QEY | | BioNTech SE (ADRs)/CapBonus/140/Call/BNP | - | - | BioNTech SE (ADRs) | 140,000 | - | -51,630 % | 13,354 % | 80,000 | 24.09.2026 | BNP Paribas | |
| PJ1QEZ | | BioNTech SE (ADRs)/CapBonus/75/Call/BNP | - | - | BioNTech SE (ADRs) | 75,000 | 9,941 % | 18,770 % | 29,600 % | 65,000 | 24.12.2026 | BNP Paribas | |
| PK3SU0 | | BioNTech SE (ADRs)/CapBonus/110/Call/BNP | - | - | BioNTech SE (ADRs) | 110,000 | - | -19,138 % | 32,850 % | 62,000 | 24.09.2026 | BNP Paribas | |
| PK3SU1 | | BioNTech SE (ADRs)/CapBonus/90/Call/BNP | - | - | BioNTech SE (ADRs) | 90,000 | - | 2,524 % | 26,351 % | 68,000 | 24.09.2026 | BNP Paribas | |
| PK3SU2 | | BioNTech SE (ADRs)/CapBonus/98/Call/BNP | - | - | BioNTech SE (ADRs) | 98,000 | - | -6,141 % | 26,351 % | 68,000 | 24.09.2026 | BNP Paribas | |
| PK3SU5 | | BioNTech SE (ADRs)/CapBonus/76/Call/BNP | - | - | BioNTech SE (ADRs) | 76,000 | 8,971 % | 17,687 % | 35,016 % | 60,000 | 24.12.2026 | BNP Paribas | |
| PK3SU6 | | BioNTech SE (ADRs)/CapBonus/92/Call/BNP | - | - | BioNTech SE (ADRs) | 92,000 | 12,438 % | 0,357 % | 35,016 % | 60,000 | 24.12.2026 | BNP Paribas | |
| PK3SU7 | | BioNTech SE (ADRs)/CapBonus/82/Call/BNP | - | - | BioNTech SE (ADRs) | 82,000 | 12,081 % | 11,188 % | 32,850 % | 62,000 | 24.12.2026 | BNP Paribas | |
| PK3SU8 | | BioNTech SE (ADRs)/CapBonus/90/Call/BNP | - | - | BioNTech SE (ADRs) | 90,000 | 13,392 % | 2,524 % | 32,850 % | 62,000 | 24.12.2026 | BNP Paribas | |
| PK3SU9 | | BioNTech SE (ADRs)/CapBonus/82/Call/BNP | - | - | BioNTech SE (ADRs) | 82,000 | 14,693 % | 11,188 % | 26,351 % | 68,000 | 24.12.2026 | BNP Paribas | |
| PK3SUZ | | BioNTech SE (ADRs)/CapBonus/74/Call/BNP | - | - | BioNTech SE (ADRs) | 74,000 | - | 19,853 % | 32,850 % | 62,000 | 24.09.2026 | BNP Paribas | |
| PK3SV0 | | BioNTech SE (ADRs)/CapBonus/120/Call/BNP | - | - | BioNTech SE (ADRs) | 120,000 | 25,593 % | -29,969 % | 24,185 % | 70,000 | 23.12.2027 | BNP Paribas | |
| PK3SV1 | | BioNTech SE (ADRs)/CapBonus/95/Call/BNP | - | - | BioNTech SE (ADRs) | 95,000 | 18,936 % | -2,892 % | 18,770 % | 75,000 | 23.12.2027 | BNP Paribas | |
| PK3SV2 | | BioNTech SE (ADRs)/CapBonus/130/Call/BNP | - | - | BioNTech SE (ADRs) | 130,000 | 30,460 % | -40,799 % | 18,770 % | 75,000 | 23.12.2027 | BNP Paribas | |
| PK3SV4 | | BioNTech SE (ADRs)/CapBonus/140/Call/BNP | - | - | BioNTech SE (ADRs) | 140,000 | - | -51,630 % | 13,354 % | 80,000 | 23.12.2027 | BNP Paribas | |
| PK3SVA | | BioNTech SE (ADRs)/CapBonus/98/Call/BNP | - | - | BioNTech SE (ADRs) | 98,000 | 21,220 % | -6,141 % | 26,351 % | 68,000 | 24.12.2026 | BNP Paribas | |
| PK3SVC | | BioNTech SE (ADRs)/CapBonus/130/Call/BNP | - | - | BioNTech SE (ADRs) | 130,000 | - | -40,799 % | 7,939 % | 85,000 | 24.12.2026 | BNP Paribas | |
| PK3SVD | | BioNTech SE (ADRs)/CapBonus/84/Call/BNP | - | - | BioNTech SE (ADRs) | 84,000 | 14,273 % | 9,022 % | 35,016 % | 60,000 | 25.03.2027 | BNP Paribas | |
| PK3SVE | | BioNTech SE (ADRs)/CapBonus/100/Call/BNP | - | - | BioNTech SE (ADRs) | 100,000 | 17,015 % | -8,307 % | 35,016 % | 60,000 | 25.03.2027 | BNP Paribas | |
| PK3SVF | | BioNTech SE (ADRs)/CapBonus/90/Call/BNP | - | - | BioNTech SE (ADRs) | 90,000 | 16,012 % | 2,524 % | 32,850 % | 62,000 | 25.03.2027 | BNP Paribas | |
| PK3SVG | | BioNTech SE (ADRs)/CapBonus/98/Call/BNP | - | - | BioNTech SE (ADRs) | 98,000 | 18,053 % | -6,141 % | 32,850 % | 62,000 | 25.03.2027 | BNP Paribas | |
| PK3SVH | | BioNTech SE (ADRs)/CapBonus/84/Call/BNP | - | - | BioNTech SE (ADRs) | 84,000 | 15,290 % | 9,022 % | 29,600 % | 65,000 | 25.03.2027 | BNP Paribas | |
| PK3SVJ | | BioNTech SE (ADRs)/CapBonus/100/Call/BNP | - | - | BioNTech SE (ADRs) | 100,000 | 20,772 % | -8,307 % | 29,600 % | 65,000 | 25.03.2027 | BNP Paribas | |
| PK3SVK | | BioNTech SE (ADRs)/CapBonus/98/Call/BNP | - | - | BioNTech SE (ADRs) | 98,000 | 22,213 % | -6,141 % | 26,351 % | 68,000 | 25.03.2027 | BNP Paribas | |
| PK3SVL | | BioNTech SE (ADRs)/CapBonus/110/Call/BNP | - | - | BioNTech SE (ADRs) | 110,000 | 26,506 % | -19,138 % | 26,351 % | 68,000 | 25.03.2027 | BNP Paribas | |
| PK3SVM | | BioNTech SE (ADRs)/CapBonus/92/Call/BNP | - | - | BioNTech SE (ADRs) | 92,000 | 21,583 % | 0,357 % | 24,185 % | 70,000 | 25.03.2027 | BNP Paribas | |
| PK3SVN | | BioNTech SE (ADRs)/CapBonus/100/Call/BNP | - | - | BioNTech SE (ADRs) | 100,000 | 25,634 % | -8,307 % | 24,185 % | 70,000 | 25.03.2027 | BNP Paribas | |
| PK3SVP | | BioNTech SE (ADRs)/CapBonus/90/Call/BNP | - | - | BioNTech SE (ADRs) | 90,000 | 21,849 % | 2,524 % | 18,770 % | 75,000 | 25.03.2027 | BNP Paribas | |
| PK3SVQ | | BioNTech SE (ADRs)/CapBonus/130/Call/BNP | - | - | BioNTech SE (ADRs) | 130,000 | 43,147 % | -40,799 % | 18,770 % | 75,000 | 25.03.2027 | BNP Paribas | |
| PK3SVV | | BioNTech SE (ADRs)/CapBonus/80/Call/BNP | - | - | BioNTech SE (ADRs) | 80,000 | 13,417 % | 13,354 % | 32,850 % | 62,000 | 23.12.2027 | BNP Paribas | |
| PK3SVW | | BioNTech SE (ADRs)/CapBonus/90/Call/BNP | - | - | BioNTech SE (ADRs) | 90,000 | 16,372 % | 2,524 % | 32,850 % | 62,000 | 23.12.2027 | BNP Paribas | |
| PK3SVX | | BioNTech SE (ADRs)/CapBonus/85/Call/BNP | - | - | BioNTech SE (ADRs) | 85,000 | 14,924 % | 7,939 % | 29,600 % | 65,000 | 23.12.2027 | BNP Paribas | |
| PK3SVY | | BioNTech SE (ADRs)/CapBonus/110/Call/BNP | - | - | BioNTech SE (ADRs) | 110,000 | 21,245 % | -19,138 % | 29,600 % | 65,000 | 23.12.2027 | BNP Paribas | |
| PK3SVZ | | BioNTech SE (ADRs)/CapBonus/90/Call/BNP | - | - | BioNTech SE (ADRs) | 90,000 | 16,898 % | 2,524 % | 24,185 % | 70,000 | 23.12.2027 | BNP Paribas | |
| UG7XR6 | | BioNTech SE (ADRs)/CapBonus/155/Call/UniCredit | - | - | BioNTech SE (ADRs) | 155,000 | - | -67,876 % | 13,354 % | 80,000 | 28.12.2026 | Unicredit | |
| UG7XR8 | | BioNTech SE (ADRs)/CapBonus/115/Call/UniCredit | - | - | BioNTech SE (ADRs) | 115,000 | 42,415 % | -24,553 % | 18,770 % | 75,000 | 28.12.2026 | Unicredit | |
| UG9KDJ | | BioNTech SE (ADRs)/CapBonus/140/Call/UniCredit | - | - | BioNTech SE (ADRs) | 140,000 | 62,225 % | -51,630 % | 17,687 % | 76,000 | 28.12.2026 | Unicredit |